|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abstract
The change from uterine quiescence to enhanced contractile
activity may be due to the differential expression of
prostaglandin receptors within the myometrium and fetal
membranes, in a temporal and topographically distinct
manner. To address this we determined the localization and
expression of the PGE2 receptor subtypes (PTGER1-4) and
the PGF2alpha receptor (PTGFR) in paired upper and lower
segment myometrium, amnion and choriodecidual samples
throughout human pregnancy, with and without labor.
All receptor subtypes were found throughout the muscle
layers in both the upper and lower uterine segments,
co-localizing with alpha smooth muscle actin. A change in
intracellular localization was observed at term labor,
where PTGER1 and PTGER4 were predominately associated with
the nucleus. Minimal changes in the expression of the PGE2
and PGF2alpha receptor subtypes were observed with
gestational age, labor, or between the upper and lower
myometrial segments. Receptor expression in maternal and
fetal tissues differed between the receptor subtypes;
PTGER1 and PTGER4 were predominately expressed in the
fetal membranes, PTGER2 was greatest in the myometrium,
while PTGER3 and PTGFR were similarly expressed in the
myometrium and fetal membranes.
Myometrial activation via the prostaglandin receptors is
perhaps more subtle and may be mediated by a balance
between one or several of the prostaglandin receptor
subtypes together with other known contraction associated
proteins. Lack of coordination in receptor expression
between the myometrium and fetal membranes may indicate
different regulatory mechanisms between these tissues as
well as an independent function for these receptors in the
amnion and choriodecidua compared to the myometrium.
Key words:
Mechanisms of Hormone Action
Parturition
Steroid hormones
Steroid hormone receptors
This article has been cited by other articles:
![]() |
F. C. Denison, S. Battersby, A. E. King, M. Szuber, and H. N. Jabbour Prokineticin-1: A Novel Mediator of the Inflammatory Response in Third-Trimester Human Placenta Endocrinology, July 1, 2008; 149(7): 3470 - 3477. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P Fischer, J. A Hutchinson, D. Farrar, P. J O'Donovan, D. F Woodward, and K. M Marshall Loss of prostaglandin F2{alpha}, but not thromboxane, responsiveness in pregnant human myometrium during labour J. Endocrinol., April 1, 2008; 197(1): 171 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Liang, S.R. Sooranna, N. Engineer, M. Tattersall, S. Khanjani, P.R. Bennett, L. Myatt, and M.R. Johnson Prostaglandin F2-alpha receptor regulation in human uterine myocytes Mol. Hum. Reprod., April 1, 2008; 14(4): 215 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Astle, R. Newton, S. Thornton, M. Vatish, and D.M. Slater Expression and regulation of prostaglandin E synthase isoforms in human myometrium with labour Mol. Hum. Reprod., January 1, 2007; 13(1): 69 - 75. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |